158 related articles for article (PubMed ID: 16007162)
1. Multiple mutations contribute to repression by the v-Erb A oncoprotein.
Lee S; Privalsky ML
Oncogene; 2005 Oct; 24(45):6737-52. PubMed ID: 16007162
[TBL] [Abstract][Full Text] [Related]
2. DNA sequence specificity of the v-erb A oncoprotein/thyroid hormone receptor: role of the P-box and its interaction with more N-terminal determinants of DNA recognition.
Smit-McBride Z; Privalsky ML
Mol Endocrinol; 1994 Jul; 8(7):819-28. PubMed ID: 7984144
[TBL] [Abstract][Full Text] [Related]
3. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
Wahlström GM; Vennström B
Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
[TBL] [Abstract][Full Text] [Related]
4. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
Wahlström GM; Harbers M; Vennström B
Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
[TBL] [Abstract][Full Text] [Related]
5. Functional interaction between the two zinc finger domains of the v-erb A oncoprotein.
Hall BL; Bonde BG; Judelson C; Privalsky ML
Cell Growth Differ; 1992 Apr; 3(4):207-16. PubMed ID: 1355356
[TBL] [Abstract][Full Text] [Related]
6. Dimerization interfaces of v-erbA homodimers and heterodimers with retinoid X receptor alpha.
Shen Q; Subauste JS
J Biol Chem; 2000 Dec; 275(52):41018-27. PubMed ID: 11018031
[TBL] [Abstract][Full Text] [Related]
7. Silencing subdomains of v-ErbA interact cooperatively with corepressors: involvement of helices 5/6.
Busch K; Martin B; Baniahmad A; Martial JA; Renkawitz R; Muller M
Mol Endocrinol; 2000 Feb; 14(2):201-11. PubMed ID: 10674394
[TBL] [Abstract][Full Text] [Related]
8. Signaling by tyrosine kinases negatively regulates the interaction between transcription factors and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) corepressor.
Hong SH; Wong CW; Privalsky ML
Mol Endocrinol; 1998 Aug; 12(8):1161-71. PubMed ID: 9717842
[TBL] [Abstract][Full Text] [Related]
9. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
10. Dimerization of v-erbA on inverted repeats.
Zubkova I; Subauste JS
Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
[TBL] [Abstract][Full Text] [Related]
11. Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product.
Sap J; Muñoz A; Schmitt J; Stunnenberg H; Vennström B
Nature; 1989 Jul; 340(6230):242-4. PubMed ID: 2569164
[TBL] [Abstract][Full Text] [Related]
12. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the DNA-binding and dominant negative activity of v-erbA homodimers.
Subauste JS; Koenig RJ
Mol Endocrinol; 1998 Sep; 12(9):1380-92. PubMed ID: 9731706
[TBL] [Abstract][Full Text] [Related]
14. V-erba homodimers mediate the potent dominant negative activity of v-erba on everted repeats.
Zubkova I; Subauste JS
Mol Biol Rep; 2004 Jun; 31(2):131-7. PubMed ID: 15293789
[TBL] [Abstract][Full Text] [Related]
15. At least three subdomains of v-erbA are involved in its silencing function.
Busch K; Martin B; Baniahmad A; Renkawitz R; Muller M
Mol Endocrinol; 1997 Mar; 11(3):379-89. PubMed ID: 9058383
[TBL] [Abstract][Full Text] [Related]
16. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
Rascle A; Ghysdael J; Samarut J
Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of thyroid hormone receptors by protein kinase A regulates DNA recognition by specific inhibition of receptor monomer binding.
Tzagarakis-Foster C; Privalsky ML
J Biol Chem; 1998 May; 273(18):10926-32. PubMed ID: 9556570
[TBL] [Abstract][Full Text] [Related]
18. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
[TBL] [Abstract][Full Text] [Related]
19. Interactions that determine the assembly of a retinoid X receptor/corepressor complex.
Ghosh JC; Yang X; Zhang A; Lambert MH; Li H; Xu HE; Chen JD
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):5842-7. PubMed ID: 11972046
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
